David Lacomis
Neurology · Pittsburgh, PANPI 1134197056
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $908 of the $1,232 with a category attached, or 73.7%. Every reported general payment came from a single manufacturer, Mitsubishi Tanabe Pharma Development America, Inc..
Across 10 payments — averaging $123.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mitsubishi Tanabe Pharma Development America, Inc.$1K
Across 37 payments — averaging $5540.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mitsubishi Tanabe Pharma Development America, Inc.$88K
- Orion Corporation$75K
- Argenx US, Inc.$23K
- Tanabe Pharma America, Inc.$19K
What the payments were for
- Travel & lodging$90874%
- Food & beverage$32426%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mitsubishi Tanabe Pharma Development America, Inc. | 10 | $1,232 |
How this compares
$1,232 in reported general payments places this provider in the 55th percentile of 941 neurology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FirdapseAmifampridine Phosphate | 36 | $766,519 |
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 18 | $719,886 |
| Radicava OrsEdaravone | 18 | $252,191 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 21 | $148,005 |
| Mycophenolate Mofetil | 130 | $21,105 |
| Riluzole | 37 | $18,283 |
| Pyridostigmine Bromide | 126 | $6,438 |
| Azathioprine | 59 | $3,604 |
| Mexiletine Hcl | 13 | $1,600 |
| Levocarnitine | 11 | $1,529 |
| Prednisone | 143 | $923 |
| Baclofen | 14 | $749 |
| Trazodone Hcl | 12 | $103 |
Paid to pharmacies, not to this prescriber.
Other neurology in Pittsburgh
- Anoopum GuptaPittsburgh$592K
- Thomas ScottPittsburgh$476K
- James ValerianoPittsburgh$416K
- Amber van LaarPittsburgh$413K
- Andrea SynowiecPittsburgh$386K
- Dolores Dominguez SantamariaPittsburgh$265K
- Heather MouryPittsburgh$186K
- Troy DesaiPittsburgh$174K
- Richard KasdanPittsburgh$172K
- David LobasPittsburgh$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.